uterine leiomyosarcoma
Showing 1 - 25 of 1,897
Locally Advanced Leiomyosarcoma, Metastatic Leiomyosarcoma, Stage III Uterine Corpus Leiomyosarcoma AJCC v8 Trial in New York
Recruiting
- Locally Advanced Leiomyosarcoma
- +5 more
- Olaparib
- +3 more
-
New York, New YorkColumbia University/Herbert Irving Cancer Center
Jan 4, 2023
LMS - Leiomyosarcoma, Uterine Leiomyosarcoma Trial in Stanford (drug, procedure, behavioral)
Suspended
- LMS - Leiomyosarcoma
- Uterine Leiomyosarcoma
- Gemcitabine
- +5 more
-
Stanford, CaliforniaStanford University
Oct 24, 2022
Locally Advanced Leiomyosarcoma, Metastatic Leiomyosarcoma, Stage III Uterine Corpus Leiomyosarcoma AJCC v8 Trial in New York
Not yet recruiting
- Locally Advanced Leiomyosarcoma
- +8 more
- Olaparib
- +3 more
- (no location specified)
Jul 6, 2022
Metastatic Leiomyosarcoma, Unresectable Leiomyosarcoma, Uterine Corpus Leiomyosarcoma Trial in Boston (Ipilimumab, Laboratory
Active, not recruiting
- Metastatic Leiomyosarcoma
- +2 more
- Ipilimumab
- +2 more
-
Boston, Massachusetts
- +1 more
Jun 28, 2022
Stage III Uterine Corpus Leiomyosarcoma AJCC v8, Stage IV Uterine Corpus Leiomyosarcoma AJCC v8 Trial in United States (Computed
Active, not recruiting
- Stage III Uterine Corpus Leiomyosarcoma AJCC v8
- Stage IV Uterine Corpus Leiomyosarcoma AJCC v8
- Computed Tomography
- +4 more
-
Phoenix, Arizona
- +14 more
Aug 23, 2022
Uterine or Soft Tissue Leiomyosarcoma Trial in Villejuif (Doxorubicin, Trabectedin)
Completed
- Uterine or Soft Tissue Leiomyosarcoma
-
Villejuif, Val De Marne, FranceGustave Roussy
Dec 10, 2021
Metastatic Leiomyosarcoma, Metastatic Soft Tissue Sarcoma, Stage III Uterine Corpus Leiomyosarcoma AJCC v8 Trial in United
Recruiting
- Metastatic Leiomyosarcoma
- +10 more
- Cabozantinib
- +3 more
-
Duarte, California
- +4 more
Nov 4, 2021
Uterine Cancer, Endometrial Carcinoma, Carcinosarcoma Trial in United States (Nivolumab)
Active, not recruiting
- Uterine Cancer
- +6 more
-
Basking Ridge, New Jersey
- +7 more
Apr 4, 2022
Early Differential Diagnosis of Uterine Leiomyomas and
Recruiting
- Leiomyoma
- Leiomyosarcoma
- Biopsy and peripheral blood collection
-
Cartagena, Murcia, Spain
- +3 more
Sep 2, 2021
Preoperative Molecular Diagnosis of Uterine Tumors by Liquid
Recruiting
- Leiomyoma, Uterine
- Leiomyosarcoma Uterus
- Collection of Leiomyoma samples
- +2 more
-
LĀ“Hospitalet de Llobregat, Barcelona, Spain
- +20 more
Sep 2, 2021
Leiomyosarcoma, Endometrial Stromal Tumors, Carcinosarcomas Uterine Trial in Graz (Vorinostat Oral Capsule)
Terminated
- Leiomyosarcoma
- +2 more
- Vorinostat Oral Capsule
-
Graz, AustriaMedical University of Graz, Clinic of Obstetrics and Gynecology
Jul 27, 2020
Molecular Mechanism Study of Uterine Sarcoma
Recruiting
- Uterine Sarcoma
- Diagnostic biomarker
-
Wuhan, Hubei, ChinaYan Li
May 21, 2023
Leiomyosarcoma or Carcinosarcoma Trial in Germany (Pazopanib plus Gemcitabine, Pazopanib)
Recruiting
- Leiomyosarcoma or Carcinosarcoma
- Pazopanib plus Gemcitabine
- Pazopanib
-
Bad Saarow, Germany
- +8 more
Nov 27, 2020
Stage IA Uterine Sarcoma, Stage IB Uterine Sarcoma, Stage IC Uterine Sarcoma Trial in Bronx (drug, radiation, other)
Terminated
- Stage IA Uterine Sarcoma
- +10 more
- Gemcitabine Hydrochloride
- +5 more
-
Bronx, New YorkAlbert Einstein College of Medicine
Dec 10, 2019
Soft Tissue Sarcoma Trial (ADI PEG20, Placebo)
Not yet recruiting
- Soft Tissue Sarcoma
- ADI PEG20
- Placebo
- (no location specified)
Jan 31, 2023
Leiomyosarcoma Trial in Beijing (Temozolomide for injection combined with epirubicin)
Recruiting
- Leiomyosarcoma
- Temozolomide for injection combined with epirubicin
-
Beijing, Beijing, ChinaCancer Hospital of Chinese Academy of Medical Sciences
Jan 11, 2022
High Grade Sarcoma, Metastatic Leiomyosarcoma, Metastatic Malignant Peripheral Nerve Sheath Tumor Trial in United States
Leiomyosarcoma Trial in France (pazopanib + gemcitabine)
Completed
- Leiomyosarcoma
- pazopanib + gemcitabine
-
Bordeaux, France
- +16 more
Jan 29, 2020
Leiomyosarcoma of Ovary, Soft Tissue Sarcoma Trial in Italy (Trabectedin, Gemcitabine, No Intervention: Observational Cohort)
Active, not recruiting
- Leiomyosarcoma of Ovary
- Soft Tissue Sarcoma
- Trabectedin
- +2 more
-
Bologna, BO, Italy
- +12 more
Oct 29, 2021
Recurrent Uterine Corpus Sarcoma, Uterine Corpus Leiomyosarcoma Trial in Philadelphia (Thalidomide, Laboratory Biomarker
Completed
- Recurrent Uterine Corpus Sarcoma
- Uterine Corpus Leiomyosarcoma
- Thalidomide
- Laboratory Biomarker Analysis
-
Philadelphia, PennsylvaniaGynecologic Oncology Group
Jul 22, 2019
Leiomyosarcoma, Uterine Tumor Trial in Houston (Letrozole)
Terminated
- Leiomyosarcoma
- Uterine Neoplasm
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Oct 23, 2018
Recurrent Uterine Corpus Sarcoma, Stage IIIA Uterine Sarcoma, Stage IIIB Uterine Sarcoma Trial in United States (biological,
Terminated
- Recurrent Uterine Corpus Sarcoma
- +6 more
- Bevacizumab
- +5 more
-
Phoenix, Arizona
- +200 more
Aug 20, 2020
Glabellar Frown Lines Trial in Canada, United States (Botulinum Toxins, Type A, Placebos)
Completed
- Glabellar Frown Lines
- Botulinum Toxins, Type A
- Placebos
-
Encinitas, California
- +13 more
Jun 29, 2022
Leiomyoma Trial in Ottawa (Supersonic Imagine Aixplorer SWE Ultrasound Imaging)
Enrolling by invitation
- Leiomyoma
- Supersonic Imagine Aixplorer SWE Ultrasound Imaging
-
Ottawa, Ontario, CanadaUniversity of Ottawa, Motor Function Measurement Laboratory
Jun 8, 2022